手术切除加术后双插管化疗治疗肝癌合并门静脉癌栓  

Clinical Study of Operation Treatment Followed with Chemotherapy Via Hepatic Artery and Portal Vein for Hepatocellular Carcinoma with Portal Vein Tumor Thrombi

作　　者：游红勇[1] 白燕[1] 陈智敏[1] 

机构地区：[1]崇州市人民医院普外科,四川崇州611230

出　　处：《四川医学》2014年第7期822-824,共3页Sichuan Medical Journal

摘　　要：目的观察手术切除加术后肝动脉和肝静脉双插管化疗治疗原发性肝癌合并门静脉癌栓的治疗效果。方法收集我院2000年1月至2011年1月期间15例肝癌合并门静脉癌栓患者临床资料,15例均采用肝癌切除加门静脉癌栓取栓术,术后采用肝动脉和肝静脉双插管微量泵灌注化疗。结果 15例患者均成功完成手术,术后1、2和3年的生存率分别为73.3%、40.0%、20.0%,平均生存时间24.8个月。结论对于肝癌合并门静脉癌栓患者,手术切除后使用肝动脉和门静脉双插管微量泵灌注化疗可有效提高治疗效果,延长患者生存时间。Objective To observe the treatment effectiveness of Operation treatment followed hepatic artery and portal vein chemotherapy for hepatocellular carcinoma （HCC） with portal vein tumor thrombi （PVTT） . Methods We collected the clinic data of 15 cases suffered from HCC with tumor thrombi in portal vein in our hospital from January 2000 to January 2011,there are 15 patients underwent hepatectomy and portal vein tumor thrombi extraction and treat with chemotherapy via hepatic artery and portal vein. Results In operation group,the 1,2and 3 year survival rates were 73. 3% ,40. 0% and 20. 0% respectively in the 15 patients,and average survival time is 24. 8 months. Conclusion Surgical intervention is effective in the treatment of HCC with PVTT, hepatic artery and portal vein chemotherapy after operation can enhance the effect and prolong the live time.

关 键 词：肝癌 门静脉癌栓 外科手术 化学疗法 

分 类 号：R735.7[医药卫生—肿瘤]